News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
February, 2025
February 2025
M T W T F S S
 12
3456789
10111213141516
17181920212223
2425262728  
Last Chance to Register for the ESTRO School 2025 Lower GI course
ESTRO/X
Feb 27, 2025, 09:01

Last Chance to Register for the ESTRO School 2025 Lower GI course

ESTRO (European SocieTy for Radiotherapy and Oncology) shared a post on X:

“Last Chance to Register!

Join the Lower GI: Technical and Clinical Challenges for Radiation Oncologists course in Lisbon (12-14 March 2025).

What to Expect:

  • Hands-on target delineation and treatment planning
  • Latest tech and techniques.”

More posts featuring ESTRO.

cancer ESTRO ESTRO School 2025 European SocieTy for Radiotherapy and Oncology Lower GI course OncoDaily Oncology
Special Coverage
Blog
Feb 27, 2025, 09:01
Last Chance to Register for the ESTRO School 2025 Lower GI course
Blog
Feb 27, 2025, 08:53
Paul Peter Tak: Positive final survival data from CAN-2409 in borderline resectable pancreatic cancer
Blog
Feb 27, 2025, 08:38
Michael Sapienza: Committed to ensuring that colorectal cancer remains a national priority
Blog
Feb 27, 2025, 08:31
World NGO Day 2025: 'Empowering Grassroots Movements for a Sustainable Future' - Lung Cancer Europe
Blog
Feb 27, 2025, 08:25
Antonio Passaro: I had the opportunity to participate in the Immuno Oncology South Africa
Blog
Feb 27, 2025, 08:16
Ashika Naik: Honoring the unwavering commitment of non-governmental organizations
Insight
Feb 27, 2025, 08:02
AMORE Project: Using Big Data to Improve Cancer Care Accessibility in Urban Areas
Blog
Feb 27, 2025, 07:45
Miriam Mutebi: Awareness must lead to action
Oncolibrary
Feb 26, 2025, 18:07
Ocular Side Effects of Chemotherapy: Understanding the Risks of Eye Toxicity
Blog
Feb 26, 2025, 16:35
Toral Shah: World cancer day 2025 reflections – Why is Integrative oncology important?
Science
Feb 26, 2025, 16:33
Hagop Kantarjian: Treatment-free remission in non-transplanted Ph+ ALL patients
Blog
Feb 26, 2025, 16:33
Iván R. González: Neoadjuvant Nivolumab Plus Ipilimumab versus Chemotherapy in Patients with Resectable NSCLC